On-Site Infusion Suite
At Hematology Oncology Care infusions are done in the privacy and harmony of our on-site suites.
On-site infusion has been proven a safe and effective alternative to inpatient care for many disease states and therapies. For many patients, receiving treatment outpatient infusion suite setting is preferable to inpatient care. Our infusion therapy suites which are ideally suited for certain patient-therapy situations.
The On-site infusion Patient approach to care offers numerous advantages such as medication use for appropriateness, effectiveness, safety, and adherence, with consideration of accessibility and cost; a collaborative approach to on-site infusion that involves the patient, oncologist, and other healthcare providers; and a focus on improving health outcomes
- An infusion therapy is mostly recommended for chemotherapy, Hormonal therapy, and during Immunotherapy.
- Often indicated for iron/vitamin deficiency anemia in patients who had a gastric bypass or any form of inflammatory bowel disease that prevents absorption of nutrients.
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications or in the case of iron or vitamins, which cannot be absorbed or tolerated by the patient.
Typically, “infusion therapy” means that a drug is administered intravenously, but the term also may refer to situations where drugs are provided through other non-oral routes, such as intramuscular injections and epidural routes (into the membranes surrounding the spinal cord).
Diseases commonly requiring infusion therapy include infections that are unresponsive to oral antibiotics, cancer and cancer-related pain, dehydration, gastrointestinal diseases or disorders, which prevent normal functioning of the gastrointestinal system and more. Other conditions treated with specialty infusion therapies may include Chemotherapy for cancers, congestive heart failure, Crohn’s Disease, hemophilia, immune deficiencies, multiple sclerosis, rheumatoid arthritis, iron/folate vitamindeficiency anemia in-patient who had a gastric bypass or any form of inflammatory bowel disease that prevents absorption of nutrients, cancer hormonal therapy, Immunotherapy and more.
Until the 1980s, patients receiving infusion therapy had to remain in the inpatient setting for the duration of their therapy. Heightened emphasis on cost-containment in healthcare, as well as developments in the clinical administration of the therapy, led to strategies to administer infusion therapy in alternate settings. For individuals requiring long-term therapy, inpatient care is not only tremendously expensive but also prevents the individual from resuming a normal lifestyle and work activities.
The information in this document does not replace a medical consultation. It is for personal guidance use only. We recommend that patients ask their doctors about what tests or types of treatments are needed for their type and stage of the disease.
- American Cancer Society
- The National Cancer Institute
- National Comprehensive Cancer Network
- American Academy of Gastroenterology
- National Institute of Health
- MD Anderson Cancer Center
- Memorial Sloan Kettering Cancer Center
- American Academy of Hematology